DETECTION OF CIRCULATING UROPLAKIN-POSITIVE CELLS IN PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER-Reference-Cited by-同舟云学术

DETECTION OF CIRCULATING UROPLAKIN-POSITIVE CELLS IN PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER

Published:1999-09 Issue:3 Part 1 Volume:162 Page:931-935
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

LI SHARON M.,ZHANG ZHONG-TING,CHAN SAMUEL,MCLENAN ORVILLE,DIXON CHRISTOPHER,TANEJA SAMIR,LEPOR HERBERT,SUN TUNG-TIEN,WU XUE-RU

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference16 articles.

1. American Cancer Society: Cancer Facts and Figures,1998

2. Bladder cancer: natural history, tumor markers and early detection strategies;Foresman;Semin. Surg. Oncol.,1997

3. Metastatic bladder cancer;Steinberg;Urol. Clin. North. Am.,1992

4. Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Cancer Marker Network;Lianes;Clin. Cancer Res.,1998

5. Biological markers of prognosis in transitional cell carcinoma of the bladder: current concepts;Aprikian;Semin. Urol.,1993

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues;Diagnostic Pathology;2022-01-14

2. Potential of the cell‑free blood‑based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma;Oncology Letters;2021-05-10

3. Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology;Urologic Oncology: Seminars and Original Investigations;2018-05

4. The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer;Translational Andrology and Urology;2017-12

5. Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer;Clinical Genitourinary Cancer;2017-08